Some of the most prominent names in biotechnology plunged on Thursday as the Nasdaq headed for its worst day in nearly two years.
Read MoreThe latest on the markets
Earnings growth will become muted and rising interest rates cap will multiple expansion, analyst Hugh Johnson says.
Jim Cramer warns of mistakes most commonly made by investors when it comes to mutual funds and ETFs.
According to Goldman Sachs strategists, the answer is simple: Bet on companies that don't see so much turnover.
Students who graduate with no debt end up being worth more than classmates with outstanding loans. Parents, start prepping now.
Get the best of CNBC in your inbox